Sarepta Therapeutics, Inc. SRPT

$SRPT FDA clears Sarepta to proceed with LGMD gene therapy trials
Investing.com
Published 15/04/2025, 13:38

$SRPT temporary halt from EMA. Going to 40

$SRPT temporary halt from EMA

$SRPT plenty of faith in this company and their pipeline. Will turn around in no time, may actually be promoted by President Trump.

1 PR is all we need

61$ soon

$SRPT Roche presenting in Texas this week

https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-149358831/news/Roche-to-share-latest-scientific-advancements-from-its-neuromuscular-portfolio-at-Muscular-Dystrophy-49346845/

$SRPT def ain’t no meme stock

$SRPT you all realize this is a prime buyout candidate 40B will be easy

$SRPT patiently waiting